参考文献/References:
[1]Quan R,Zhang H,Li Z,et al.Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide[J].Medicine (Baltimore),2020,99(2):e18591. [2]Ostrom QT,Gittleman H,Truitt G,et al.CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015[J].Neuro Oncol,2018,20(suppl_4):iv1-iv86. [3]Ung TH,Ney DE,Damek D,et al.The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma[J].Neurosurgery,2019,84(3):687-695. [4]El Nady HG,Kholoussi N,Sherif LS,et al.Triggering Receptor Expressed on Myeloid Cells-1(TREM-1)as a New Marker in Ventilated Children with Pneumonia[J].Biomedical and Pharmacology Journal,2019,12(4):1951-1959. [5]Grivennikov SI,Greten FR,Karin M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899. [6]潘薇,陈瑞,张忠涛.TREM-1和HMG B1在老年直肠癌患者肿瘤组织中的表达及其与预后的关系[J].中国现代普通外科进展,2019,22(5):378-380,385. [7]朱亚飞,张振东,高国兰.髓系细胞触发受体-1在人卵巢癌组织中的表达及其与淋巴结转移的相关性研究[J].现代妇产科进展,2013,22(1):6-9. [8]李皖云,张娜,欧玉荣,等.髓样细胞触发受体-1与肝细胞癌发生和发展的相关性[J].南方医科大学学报,2015,35(12):1705-1709,1720. [9]王璐,孙小虎,白静慧,等.TREM-1和EGFR在结肠癌组织中表达及意义[J].中西医结合心血管病电子杂志,2018,6(31):3-6. [10]Rhodes DR,Kalyana-Sundaram S,Mahavisno V,et al.Oncomine 3.0:genes,pathways,and networks in a collection of 18,000 cancer gene expression profiles[J].Neoplasia(New York,NY),2007,9(2):166-180. [11]刘洪军,漆建,尹久,等.基于Oncomine数据库及GEPIA数据库分析CHI3L2基因在胶质母细胞瘤中的表达及与预后的相关性[J].现代肿瘤医学,2020,28(20):47-51. [12]Mering C,Huynen M,Jaeggi D,et al.STRING:a database of predicted functional associations between proteins[J].Nucleic Acids Research,2003,31(1):258-261. [13]Vasilev A,Sofi R,Rahman R,et al.Using Light for Therapy of Glioblastoma Multiforme (GBM) [J].Brain Sci,2020,10(2):75. [14]Rajaratnam V,Islam MM,Yang M,et al.Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments[J].Cancers (Basel),2020,12(4):937. [15]Shen ZT,Sigalov AB.Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer[J].Mol Pharm,2017,14(12):4572-4582. [16]Saurer L,Zysset D,Rihs S,et al.TREM-1 promotes intestinal tumorigenesis[J].Sci Rep,2017,7(1):14870. [17]Duan M,Wang ZC,Wang XY,et al.TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression[J].Ann Surg Oncol,2015,22(9):3121-3129.
相似文献/References:
[1]张伟斌,荆国杰.胶质母细胞瘤信号通路的研究[J].医学信息,2019,32(23):33.[doi:10.3969/j.issn.1006-1959.2019.23.009]
ZHANG Wei-bin,JING Guo-jie.Study on Glioblastoma Signaling Pathway[J].Medical Information,2019,32(09):33.[doi:10.3969/j.issn.1006-1959.2019.23.009]
[2]初晓玲,吴 波,蓝晓红,等.胶质母细胞瘤耐药性基因筛选及治疗药物预测[J].医学信息,2024,37(19):10.[doi:10.3969/j.issn.1006-1959.2024.19.002]
CHU Xiaoling,WU Bo,LAN Xiaohong,et al.Drug Resistance Gene Screening and Therapeutic Drug Prediction of Glioblastoma[J].Medical Information,2024,37(09):10.[doi:10.3969/j.issn.1006-1959.2024.19.002]